The Fred Hutch Institutional Biosafety Committees (IBC) review, approve, and oversee research conducted in specific locations involving the use of recombinant or synthetic DNA/RNA and other biohazards (e.g., infectious agents).
Beginning June 1, 2025, approved minutes from all IBC meetings will be made publicly available here in accordance with NIH guidelines.